Sarki A Abdulkadir (S A Abdulkadir)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Benign Prostatic Hyperplasia

Gene Expression

Top Venues

Nature communications

Cancer research

Prostate cancer and prostatic diseases

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Sukanya Panja, Mihai Ioan Truica, Christina Y Yu, Vamshi Saggurthi, Michael W Craige, Katie Whitehead, Mayra V Tuiche, Aymen Al-Saadi, Riddhi Vyas, Shridar Ganesan, Suril Gohel, Frederick Coffman, James Scott Parrott, Songhua Quan, Shantenu Jha, Isaac Kim, Edward M Schaeffer, Vishal Kothari, Sarki A Abdulkadir, Antonina Mitrofanova
Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC. Nature communications 15 (1) (2024)
Sukanya Panja, Mihai Ioan Truica, Christina Y Yu, Vamshi Saggurthi, Michael W Craige, Katie Whitehead, Mayra V Tuiche, Aymen Al-Saadi, Riddhi Vyas, Shridar Ganesan, Suril Gohel, Frederick Coffman, James Scott Parrott, Songhua Quan, Shantenu Jha, Isaac Kim, Edward M Schaeffer, Vishal Kothari, Sarki A Abdulkadir, Antonina Mitrofanova
Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC. Nature communications 15 (1) (2024)
Young A Yoo, Songhua Quan, William Yang, Qianyu Guo, Yara Rodríguez, Zachary R Chalmers, Mary F Dufficy, Barbara Lackie, Vinay Sagar, Kenji Unno, Mihai Ioan Truica, Navdeep S Chandel, Sarki A Abdulkadir
Asparagine Dependency is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer. Cancer research (2024)
Young A Yoo, Songhua Quan, William Yang, Qianyu Guo, Yara Rodríguez, Zachary R Chalmers, Mary F Dufficy, Barbara Lackie, Vinay Sagar, Kenji Unno, Mihai Ioan Truica, Navdeep S Chandel, Sarki A Abdulkadir
Asparagine Dependency is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer. Cancer research (2024)
Sukanya Panja, Mihai Ioan Truica, Christina Y Yu, Vamshi Saggurthi, Michael W Craige, Katie Whitehead, Mayra V Tuiche, Aymen Al-Saadi, Riddhi Vyas, Shridar Ganesan, Suril Gohel, Frederick Coffman, James Scott Parrott, Songhua Quan, Shantenu Jha, Isaac Kim, Edward M Schaeffer, Vishal Kothari, Sarki A Abdulkadir, Antonina Mitrofanova
Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC. Nature communications 15 (1) (2024)
Sukanya Panja, Mihai Ioan Truica, Christina Y Yu, Vamshi Saggurthi, Michael W Craige, Katie Whitehead, Mayra V Tuiche, Aymen Al-Saadi, Riddhi Vyas, Shridar Ganesan, Suril Gohel, Frederick Coffman, James Scott Parrott, Songhua Quan, Shantenu Jha, Isaac Kim, Edward M Schaeffer, Vishal Kothari, Sarki A Abdulkadir, Antonina Mitrofanova
Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC. Nature communications 15 (1) (2024)
Sukanya Panja, Mihai Ioan Truica, Christina Y Yu, Vamshi Saggurthi, Michael W Craige, Katie Whitehead, Mayra V Tuiche, Aymen Al-Saadi, Riddhi Vyas, Shridar Ganesan, Suril Gohel, Frederick Coffman, James Scott Parrott, Songhua Quan, Shantenu Jha, Isaac Kim, Edward M Schaeffer, Vishal Kothari, Sarki A Abdulkadir, Antonina Mitrofanova
Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC. Nature communications 15 (1) (2024)
Young A Yoo, Songhua Quan, William Yang, Qianyu Guo, Yara Rodríguez, Zachary R Chalmers, Mary F Dufficy, Barbara Lackie, Vinay Sagar, Kenji Unno, Mihai Ioan Truica, Navdeep S Chandel, Sarki A Abdulkadir
Asparagine Dependency is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer. Cancer research (2024)
Yara Rodríguez, Kenji Unno, Mihai Ioan Truica, Zachary R Chalmers, Young A Yoo, Rajita Vatapalli, Vinay Sagar, Jindan Yu, Barbara Lysy, Maha Hussain, Huiying Han, Sarki A Abdulkadir
A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer. Cancer research 82 (11) (2022)
Austin G Holmes, J Brandon Parker, Vinay Sagar, Mihai Ioan Truica, Pritin N Soni, Huiying Han, Gary E Schiltz, Sarki A Abdulkadir, Debabrata Chakravarti
A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression. Science advances 8 (17) (2022)
Anuj S Desai, Vinay Sagar, Barbara Lysy, Adam B Weiner, Oliver S Ko, Conor Driscoll, Yara Rodriguez, Rajita Vatapalli, Kenji Unno, Huiying Han, Jason E Cohen, Amanda X Vo, Minh Pham, Michael Shin, Ketan Jain-Poster, Jennifer Ross, Elizabeth G Morency, Travis J Meyers, John S Witte, Jennifer Wu, Sarki A Abdulkadir, Shilajit D Kundu
Inflammatory bowel disease induces inflammatory and pre-neoplastic changes in the prostate. Prostate cancer and prostatic diseases (2021)
Zachary R Chalmers, Michael C Burns, Ericka M Ebot, Garrett M Frampton, Jeffery S Ross, Maha H A Hussain, Sarki A Abdulkadir
Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusions. Prostate cancer and prostatic diseases 24 (2) (2021)
Anuj S Desai, Vinay Sagar, Barbara Lysy, Adam B Weiner, Oliver S Ko, Conor Driscoll, Yara Rodriguez, Rajita Vatapalli, Kenji Unno, Huiying Han, Jason E Cohen, Amanda X Vo, Minh Pham, Michael Shin, Ketan Jain-Poster, Jennifer Ross, Elizabeth G Morency, Travis J Meyers, John S Witte, Jennifer Wu, Sarki A Abdulkadir, Shilajit D Kundu
Correction: Inflammatory bowel disease induces inflammatory and preneoplastic changes in the prostate. Prostate cancer and prostatic diseases (2021)
R Vatapalli, V Sagar, Y Rodriguez, J C Zhao, K Unno, S Pamarthy, B Lysy, Jonathan F Anker, H Han, Y A Yoo, M Truica, Z R Chalmers, F Giles, Jindan Yu, Debabrata Chakravarti, B Carneiro, Sarki A Abdulkadir
Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. Nature communications 11 (1) (2020)